Literature DB >> 10422040

Psychological effects of hormone replacement therapy: a comparison of tibolone and a sequential estrogen therapy.

L A Ross1, E M Alder, E H Cawood, J Brown, A E Gebbie.   

Abstract

Hormone replacement therapy (HRT) is effective in alleviating vasomotor symptoms but the effect on psychological symptoms is less clear. This study aimed to compare the psychological effects of two regimens of HRT in perimenopausal women in a randomized, initially double-blind, controlled trial. Thirty-eight women reporting climacteric symptoms were randomly allocated into either oral conjugated equine estrogen 0.625 mg daily plus progestogen (norgestrel) 150 micrograms for the last 12 days of each 28 day cycle, or tibolone 2.5 mg/day for 28 days. They were assessed using standardized psychological assessments. There were no significant differences in changes from baseline between the two types of therapy. For both groups combined there were significant improvements compared with baseline in vasomotor symptoms in the first month, plus anxiety, sleep, memory and somatic dysfunction by the second and third months, but not in scores of depression. Log linear analysis of weekly scores showed that depression scores were significantly related to improvement in vasomotor scores independent of type of therapy and time on HRT. Memory problems were related to vasomotor symptoms independent of depression. No difference between the two types of therapy was found, nor any direct effect of HRT on anxiety or depression. The results support the domino theory, suggesting that psychological improvement follows alleviation of vasomotor symptoms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10422040     DOI: 10.3109/01674829909075581

Source DB:  PubMed          Journal:  J Psychosom Obstet Gynaecol        ISSN: 0167-482X            Impact factor:   2.949


  4 in total

Review 1.  Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Authors:  Richard J Santen; D Craig Allred; Stacy P Ardoin; David F Archer; Norman Boyd; Glenn D Braunstein; Henry G Burger; Graham A Colditz; Susan R Davis; Marco Gambacciani; Barbara A Gower; Victor W Henderson; Wael N Jarjour; Richard H Karas; Michael Kleerekoper; Roger A Lobo; JoAnn E Manson; Jo Marsden; Kathryn A Martin; Lisa Martin; JoAnn V Pinkerton; David R Rubinow; Helena Teede; Diane M Thiboutot; Wulf H Utian
Journal:  J Clin Endocrinol Metab       Date:  2010-06-21       Impact factor: 5.958

Review 2.  Hormone replacement therapy in the treatment of perimenopausal depression.

Authors:  Jennifer L Gordon; Susan S Girdler
Journal:  Curr Psychiatry Rep       Date:  2014-12       Impact factor: 5.285

Review 3.  Short-term and long-term effects of tibolone in postmenopausal women.

Authors:  Giulio Formoso; Enrica Perrone; Susanna Maltoni; Sara Balduzzi; Jack Wilkinson; Vittorio Basevi; Anna Maria Marata; Nicola Magrini; Roberto D'Amico; Chiara Bassi; Emilio Maestri
Journal:  Cochrane Database Syst Rev       Date:  2016-10-12

Review 4.  Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence.

Authors:  Maria Garefalakis; Martha Hickey
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.